Targeting B7x and B7 H3 as New Immunotherapies for Prostate Cancer
Abstract
We have made good progress during the current funding period. We have established systems to generate humanand mouse B7-H3 fusion proteins and then used them to immunize B7-H3 gene knock mice. Two of immunized B7-H3-/- micegenerated good anti-B7-H3 antibodies in the blood and therefore one of these mice were used to generate hybridomas. Wealso have developed FACS-based approach to screen hybridomas and to exclude cross-reactive hybridomas. Finally, we havegenerated eight B7-H3-specific mAbs.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2015
- Accession Number
- AD1002635
Entities
People
- Xingxing Zang
Organizations
- Albert Einstein College of Medicine